Can the Ronnie Gardiner Method improve thinking and daily function in people with Parkinson’s

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial tests whether a multimodal Ronnie Gardiner Method (RGM) program can improve cognitive functions in adults with idiopathic Parkinson’s disease at early to mid stages. Participants attend weekly 1.5-hour group sessions for 10 weeks, with additional home practice, while maintaining stable medication. Before and after the program, researchers collect data on cognition, motor symptoms, balance, mood, and quality of life, plus participant experiences with the sessions. The RGM approach uses rhythm, music, movement, speech, reading symbols, and multisensory cues to stimulate brain function and mobility. This study takes place within the Ghent rehabilitation and Parkinson’s program in Belgium, under university supervision.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* diagnosis of idiopathic Parkinson's disease
* safe, independent mobility and participation (Hoehn and Yahr stages 1-3)
* a stable dopaminergic medication regimen for at least 4 weeks prior to study participation
* willingness and ability to participate in a 10-week intervention program
* willingness to participate in the study (signing of informed consent)

Exclusion Criteria:

* Presence of other neurological or severe psychiatric conditions that could interfere with participation or the interpretation of results (e.g., substance use disorder, severe depression, psychosis)
* Severe visual or hearing impairments that limit the ability to follow group instructions as determined by a physician.
* Physical limitations that inhibit safe participation in moderate-to-vigorous exercise or group rehabilitation.

Where it's running

• University Hospital Ghent
  Ghent, Oost-Vlaanderen, Belgium Recruiting

Study contacts

• Study coordinator: Wim De Wilde, MSc
• Email: Wim.dewilde@ugent.be
• Phone: +32 472 57 58 08

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Parkinson’s Risk in Gaucher Disease Type 1

  This study tests how Parkinson’s risk relates to GBA1-related Gaucher disease in adults over 40, by collecting detailed clinical data and samples for future research.

  Recruiting Icahn School of Medicine at Mount Sinai · New York, New York · NCT07886879

• Effects of excitatory and inhibitory LIFUS of GPi in Parkinson’s patients without DBS

  This study tests two deep-brain focused ultrasound patterns on people with Parkinson’s to see if they change task performance and tremor, compared with a sham stimulation.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07846007

• Capacitive-resistive radiofrequency therapy for people with Parkinson's disease

  This study tests four TECAR therapy protocols on the legs to see which best reduces muscle stiffness and improves walking in people with Parkinson's disease.

  Recruiting Universidad San Jorge · Zaragoza, Zaragoza · NCT07842926

• TRB-001 safety and immune response in early Parkinson's disease

  This early-phase study tests TRB-001 against placebo to see if it is safe and prompts an immune response in people with recently diagnosed Parkinson’s disease.

  Recruiting Phase 1 Tridem Bioscience FlexCo · Vienna · NCT07840027

• Bayesian optimization to tune DBS for better gait in Parkinson’s patients

  This study tests whether using Bayesian optimization can quickly find DBS settings that lengthen step length in people with Parkinson's who already have DBS in place.

  Recruiting Early Phase 1 University of Minnesota · Minneapolis, Minnesota · NCT07835308

• rTMS-primed self-controlled practice for people with Parkinson’s disease

  This study tests whether priming motor training with rTMS and letting people with Parkinson’s control their practice improves motor learning and motivation.

  Recruiting National Taiwan University Hospital · Taipei, Zhongzheng Dist. · NCT07832695

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.